Mantra Bio

Home | Mantrabio

South San Francisco, United States · Founded 2016 · $39.0M raised

Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$39.0M
Last Round
$9.0M Series AJan 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 3 investors for this company. The full record is or through the API.

About

Mantra Bio develops targeted exosome-based therapeutics using its proprietary REVEAL platform, which combines computational biology with lab automation to engineer exosomes — natural cellular nanoparticles — as delivery vehicles for medicines. Founded in 2016, the company originally developed its technology at the Illumina Accelerator and is headquartered in South San Francisco, California, where it works to harness exosomes for safe, highly targeted drug delivery.

Summary

Mantra Bio is a Biotech company based in South San Francisco, United States, founded in 2016. It has raised $39.0M in total across 3 rounds, most recently a $9.0M Series A round in Jan 2023. Investors include 8VC, Viking Global and Allen & Company.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A2023 (est.)
$9.0M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Enveda

Enveda reads and translates nature’s hidden chemistry to accelerate the discovery of better medic...

Boulder, United States201–500Biotech, Artificial Intelligence
Series ETotal funding$1.1BSep 2026
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension RoundTotal funding$821.8MSep 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mantra Bio on Indexed.vc
<a href="https://indexed.vc/companies/mantra-bio"><img src="https://indexed.vc/api/badge/company/mantra-bio" alt="Mantra Bio on Indexed.vc" width="260" height="76" /></a>